Remove 2030 Remove Clinical Research Remove Disease
article thumbnail

Best-in-Class Solutions Accelerate Development of GLP-1 Therapeutics

PPD

Last year, an American Heart Association presidential advisory for the first time formally identified the strong connections between cardiovascular disease (CVD), kidney disease, Type 2 diabetes and obesity as reason to define cardiovascular-kidney-metabolic (CKM) syndrome.

article thumbnail

How organoids can redefine pre-clinical research

Drug Target Review

The substantial value of organoids is becoming increasingly recognised by supportive government initiatives developing novel drugs, with a growth rate of 22 percent between 2023 and 2030 and a market size predicted to reach over US $6.5 billion by 2030. Human organoids in basic research and clinical applications.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research

Vial

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research Randomized clinical trials are the gold-standard of evidence-based medicine, representing the culmination of the long, arduous drug development pipeline. What is a Pre-Clinical CRO? between 2024 and 2030. between 2024 and 2030.

article thumbnail

Updates in the Ophthalmology Clinical Landscape

Vial

Yet, hereditary and age-related retinal diseases present challenges, often leading to progressive vision loss and potential blindness. The urgency for novel therapeutic approaches makes ophthalmology a rapidly growing domain of clinical research. Specifically, the global ophthalmic clinical trials market, valued at USD 1.5

article thumbnail

What is the role of a CRO in a clinical trial?

Vial

In recent years, however, clinical trials have become increasingly complex, adding burden to research teams and clinical research sites. Starting with describing challenges faced in managing clinical trials, we explore how CROs address challenges and how sponsors benefit from partnering with CROs. billion in 2030.

article thumbnail

7 Most Common Types of Depression

Olympian Clinical Research

Major depressive disorder ( MDD ), also known as clinical depression, is characterized by a persistent feeling of sadness or emptiness lasting for at least two weeks. According to the World Health Organization, major depressive disorder is projected to rank first as the top burden of disease worldwide by 2030.

article thumbnail

World Heart Day 2020: From our heart to yours

The Pharma Data

Cardiovascular disease (CVD) is a general term for conditions affecting the heart or blood vessels. CVD has many causes: from smoking, diabetes, high blood pressure and obesity, to air pollution, genetic risk factors and less common conditions such as Chagas disease. Developing next-generation therapies.

Disease 52